Inhibition of 3′,5′-nucleotide phosphodiesterase and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo
- 1 October 1976
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 15 (10) , 609-612
- https://doi.org/10.1016/0028-3908(76)90016-2
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3′,5′-monophosphate phosphodiesteraseCellular and Molecular Life Sciences, 1975
- Cyclic adenosine 3′,5′-monophosphate role in the physiology and pharmacology of the central nervous systemBiochemical Pharmacology, 1975
- Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug DevelopmentJournal of Pharmaceutical Sciences, 1975
- Histamine H2 receptors and cyclic AMP in brainLife Sciences, 1974
- IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3′,5′‐MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION WITH PHOSPHORYLASE ACTIVATIONJournal of Neurochemistry, 1974
- Cerebral phosphodiesterase and the dopamine receptorJournal of Pharmacy and Pharmacology, 1973
- Effects of neurohumoral and adrenergic agents on cyclic amp levels in various areas of the rat brain in vitroNeuropharmacology, 1973
- The adenosine 3′,5′-monophosphate content of brain tissue obtained by an ultra-rapid freezing techniqueBrain Research, 1973
- A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphateBiochemical Journal, 1971
- Effect of Norepinephrine, Histamine and Other Drugs on Cyclic 3’, 5’-AMP Formation in Brain Slices of Various Animal SpeciesPharmacology, 1971